About BiosparQ

BiosparQ B.V. is a privately-held in vitro diagnostics company dedicated to provide healthcare professionals with a unique solution for rapid diagnostics of infectious diseases that improves patient outcomes, lowers healthcare costs and helps turn back Antimicrobial Resistance (AMR).

BiosparQ has focused its efforts on research into and the development of the Cirrus D20 medical diagnostic platform, based on proprietary DigiTOF® technology. This technology enables direct analysis of patient samples using a Single-cell MALDI-TOF approach. DigiTOF® was initially developed by the TU Delft (Prof. J. Marijnissen et.al.) in co-operation with the Dutch Contract Research Organization TNO, under contracts of the US and Dutch Ministries of Defense in the early 2000s.

After incorporation and closing of seed funding rounds in 2009, BiosparQ began as a virtual company based in Delft. In 2012, a substantial series A round was closed, which enabled BiosparQ to grow into a fully integrated company.  All DigiTOF® assets from TU Delft / TNO was acquired (Patent portfolio and Cirrus D20 prototype hard- and software). It was decided move to the Leiden Bioscience Park, renting well equipped laboratories and offices from Biopartner foundation.

In 2016 a series B funding round was closed and in 2018 the company was granted an Innovation Credit by the Dutch government, enabling the company to mature the Cirrus D20 platform and develop, validate and certify the first applications.

Since 2009, the BiosparQ established an international network of clinical partners that support the company to create the applications pipeline. Several (inter)national subsidies were granted to the BiosparQ and its partners. In 2018, a supply chain consisting of high-tech suppliers was created to prepare for production qualification.

Contact

BiosparQ B.V.
Galileïweg 8
NL-2333 BD Leiden
The Netherlands

info@biosparq.nl

https://www.biosparq.nl

News items

QuApps Online Workshop on Applications on Quantum Technologies

As an additional event, in preparation for the QuApps conference…

RAAK MKB Indieningsronde maart 2021

Op deze pagina vind je in het kort de belangrijkste informatie…
14 januari 2021/door Aurélie Veltema

MinacNed pre-events in 2021: We hebben uw input nodig

In 2021 gaat het MinacNed team door met organiseren van de iMNC-pre-events,…
13 januari 2021/door Aurélie Veltema

Quantum Delta NL virtual launch event

We’re excited to invite you for thé Dutch quantum start of…

QuTech, KPN, SURF en OPNT bouwen samen aan quantumnetwerk

QuTech (een samenwerking tussen TU Delft en TNO), KPN, SURF en…
11 januari 2021/door Aurélie Veltema

The 34th International Conference on Micro Electro Mechanical Systems (IEEE MEMS 2021)

The 34th IEEE International Conference on Micro Electro Mechanical…

Online Artificial Intelligence (AI) Mission France

Are you active in the field of Artificial Intelligence (AI)?…

MinacNed members showcase their company in promotional video

To showcase the partners in the nanotechnology ecosytem, MinacNed…
6 januari 2021/door Aurélie Veltema

IVAM booth at CMEF 2021 Asia Pacific’s leading medical industry platform

For the third time, the IVAM Microtechnology Network is going…

Key Technologies pre-registration call

Consortia including research institutes and public and private…
9 december 2020/door Aurélie Veltema

Venture Challenge: Registration open for new edition

From this week onwards, starting entrepreneurs in the…
8 december 2020/door Aurélie Veltema

Open platform technologies can give medical start-ups a boost

The medical market can learn a thing from the consumer electronics…
1 december 2020/door Aurélie Veltema